FDA Recalls For Dec. 24, 2014, And Jan. 7, 2015
This article was originally published in The Tan Sheet
Recalls reported by FDA for OTC drugs, nutritionals and personal care products.
You may also be interested in...
More extensive labeling for probiotics and more stringent GMPs for live microorganism production already are required in Canada, says physician and researcher Pieter Cohen in JAMA Internal Medicine. "Consumers and physicians should not assume that the label on probiotic supplements provides adequate information to determine if consuming the live microorganism is worth the risk," he says.
After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.